Cargando…
Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson’s
This study presents an alternative therapy to conventional anti-Parkinson’s treatment strategies; where motor and non-motor symptomatic complications are considered. Thus; providing sustainability, patient compliance, therapeutic safety and efficiency, based on triggering secretion of endogenous dop...
Autor principal: | Higazy, Iman M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950972/ https://www.ncbi.nlm.nih.gov/pubmed/31920431 http://dx.doi.org/10.1016/j.jsps.2019.11.004 |
Ejemplares similares
-
Development of Lipomer Nanoparticles for the Enhancement of Drug Release, Anti-Microbial Activity and Bioavailability of Delafloxacin
por: Anwer, Md. Khalid, et al.
Publicado: (2020) -
Anti-Epileptogenic Effects of Antiepileptic Drugs
por: Miziak, Barbara, et al.
Publicado: (2020) -
Lipome géant palpébral droit
por: Napo, Abdoulaye, et al.
Publicado: (2017) -
Lipomics: A Potential Carrier for the Intravenous Delivery of Lipophilic and Hydrophilic Drugs
por: Ramírez-Hernández, David, et al.
Publicado: (2022) -
Development of dual-drug-loaded stealth nanocarriers for targeted and synergistic anti-lung cancer efficacy
por: Chen, Juan, et al.
Publicado: (2018)